The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment

Jahanara Rajwani; Danyel Evseev; Esha S. Kaul; Douglas J. Mahoney

Molecular Therapy: Oncology (Mar 2024)

The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment

Jahanara Rajwani,
Danyel Evseev,
Esha S. Kaul,
Douglas J. Mahoney

Affiliations

Jahanara Rajwani: Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada
Danyel Evseev: Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada
Esha S. Kaul: Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; The Calvin, Joan and Phoebe Snyder Institute for Chronic Disease, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada
Douglas J. Mahoney: Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Alberta Children’s Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; The Calvin, Joan and Phoebe Snyder Institute for Chronic Disease, University of Calgary, Calgary, AB T2N 4N1, Canada; Department of Microbiology, Immunology, and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada; Corresponding author: Douglas J. Mahoney, Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.

Journal volume & issue: Vol. 32, no. 1
p. 200774

Abstract

Read online

The 15th International Oncolytic Virotherapy Conference took place in Banff, Alberta, and showcased diverse new approaches to enhancing oncolytic virus therapy. A reflective keynote highlighted industry challenges and lessons. Presentations covered preclinical advancements, combination therapies, mechanisms and biomarkers, and many examples of clinical efficacy against various cancers.

Published in Molecular Therapy: Oncology

ISSN: 2950-3299 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://www.cell.com/molecular-therapy-family/oncology/home

About the journal